Tokyo, Japan

Shigeru Kyuwa

This inventor holds 1 USPTO granted patent. Top assignees: The University of Tokyo, Tk Health Research, Co, Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeru Kyuwa. Retrieved from https://idiyas.com/inventor/shigeru-kyuwa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shigeru Kyuwa: Innovator in Ophthalmic Composition

Introduction

Shigeru Kyuwa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of ophthalmology through his innovative research and development of ophthalmic compositions. His work focuses on addressing various ophthalmic diseases and disorders.

Latest Patents

Kyuwa holds a patent for an ophthalmic composition containing a clathrated antioxidant substance. This invention provides a solution for treating or preventing ophthalmic diseases, including dry eye, conjunctivitis, and age-related macular degeneration. The composition aims to enhance the quantity of tears and mucin, thereby alleviating symptoms associated with these conditions.

Career Highlights

Throughout his career, Shigeru Kyuwa has worked with prominent organizations, including Tk Health Research Co., Ltd. and The University of Tokyo. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Kyuwa has collaborated with esteemed colleagues such as Junwen Qin and Yuji Takahashi. These partnerships have further enriched his research endeavors and have led to advancements in ophthalmic treatments.

Conclusion

Shigeru Kyuwa's innovative work in ophthalmic compositions demonstrates his commitment to improving eye health. His contributions are vital in the ongoing fight against ophthalmic diseases and disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…